Compositions and methods for treating diseases and or disorders, including hyperglycemia and/or diabetes, and obesity in a subject are provided. In particular, a dry powder oral inhalation system is provided comprising, a dry powder composition of GLP-1 analogs, including PEGylated-GLP-1 molecules and a diketopiperazine.
